Articles, guides, and regulatory updates from our community.
New research reveals how repurposing existing drugs could offer faster, safer therapeutic options for Alzheimer's disease treatment and prevention.
By Peptide Association Research Team
New research reveals how existing drugs like metformin and GLP-1 agonists may offer alternative approaches to Alzheimer's treatment through repurposing strategies.
By Peptide Association Research Team
New research reveals how existing medications could be repurposed for Alzheimer's disease treatment, offering hope beyond current limited therapies.
By Peptide Association Research Team
New research explores repurposing existing drugs for Alzheimer's treatment, highlighting mitochondrial-targeted therapies and multi-target approaches.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may improve survival in hepatitis B-related liver failure by restoring immune balance. Clinical trial data and implications.
By Peptide Association Research Team